New Strategies For Enhancing Chimeric Antigen Receptor (Car) T Cell Therapy For Cancer

Grant number: 1136680 | Funding period: 2018 - 2022



The role of the immune system in cancer is now recognised as highly important, highlighted by the success of immunotherapy in patients. Yet many patients fail to respond to this form of treatment due to low frequency of lymphocytes present at the tumor site. A new form of immunotherapy involving transfer of gene-modified lymphocytes is a potential way to overcome this problem. This project will explore new strategies to enhance the utility of this approach against blood and solid cancers.

Related publications (7)